SCHEMBL347719

SCHEMBL347719

CCCCCCCCOc1ccc2c(c1)oc1cc(OCCCCCCCC)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.54
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
CA6 P23280 2/20 0.54
CA7 P43166 2/20 0.54
CA9 Q16790 2/20 0.54
CA14 Q9ULX7 2/20 0.54
CA5B Q9Y2D0 2/20 0.54
CA3 P07451 1/20 0.54
CA4 P22748 1/20 0.54
NR5A1 Q13285 1/20 0.51
ALDH2 P05091 1/20 0.51
TSHR P16473 2/20 0.50
MAOA P21397 2/20 0.50
MAOB P27338 2/20 0.50
XDH P47989 2/20 0.49
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7758792 0.87 KDM4E (0.60) CA12CA1CA2CA6CA7
SCHEMBL346823 0.86 NR5A1 (0.51) CA12CA1CA2CA6CA7
SCHEMBL367004 0.86 NR5A1 (0.51) CA12CA1CA2CA6CA7
SCHEMBL8961840 0.85 XDH (0.65) CA12CA1CA2CA6CA7
SCHEMBL16806143 0.84 ALDH1A1 (0.48) CA12CA1CA2CA6CA7
SCHEMBL16806167 0.84 ALDH1A1 (0.48) CA12CA1CA2CA6CA7
SCHEMBL16806118 0.84 ALDH1A1 (0.48) CA12CA1CA2CA6CA7
SCHEMBL16806201 0.84 XDH (0.61) CA12CA1CA2CA6CA7
SCHEMBL8868004 0.83 XDH (0.72) NR5A1ALDH2XDHALDH1A1MAPT
SCHEMBL16981581 0.83 CA12 (0.46) CA12CA1CA2CA6CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120016147-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-19 US disclosed
US-8048982-B2 Method for producing aromatic compound polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-11-01 US disclosed
EP-2241548-A1 Vanadium di-nuclear complex Sumitomo Chemical Company, Limited (JP) 2010-10-20 EP disclosed
EP-2241547-A1 Method for producing aromatic compound polymer Sumitomo Chemical Company, Limited (JP) 2010-10-20 EP disclosed
US-20090018309-A1 Method for Producing Aromatic Compound Polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-15 US disclosed
EP-1767560-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER Sumitomo Chemical Company, Limited (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018309-A1 Method for Producing Aromatic Compound Polymer PAH, MAOA, AHR CA12 1989/4885CA1 2804/4885CA2 1431/4885
US-20120016147-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER PAH, MAOA, AHR CA12 1977/4885CA1 2812/4885CA2 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.